TTM Technologies Free cash flow decreased by 1217.6% to -$85.11M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.0%, from -$73.97M to -$85.11M. Over 2 years (FY 2021 to FY 2024), Free cash flow shows a downward trend with a -27.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $34.07M | $0.00 | $42.50M | $12.55M | $52.84M | $53.69M | $50.92M | $24.08M | $25.15M | $1.40M | -$5.45M | $2.39M | $24.19M | $30.02M | -$73.97M | $42.35M | -$6.46M | -$85.11M |
| QoQ Change | — | -100.0% | — | -70.5% | +321.1% | +1.6% | -5.2% | -52.7% | +4.5% | -94.5% | -490.5% | +143.8% | +913.9% | +24.1% | -346.4% | +157.3% | -115.3% | <-999% |
| YoY Change | — | — | — | — | +55.1% | — | +19.8% | +91.9% | -53.2% | -97.3% | -122.6% | — | -3.8% | >999% | <-999% | +75.1% | -121.5% | -15.0% |